Nagichettiar Satyamurthy

Barry University — United States

Medicine · Health Sciences

57h-index14.4kcitations256works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(81), Fluorine in Organic Chemistry(42), Radiopharmaceutical Chemistry and Applications(26), Cancer, Hypoxia, and Metabolism(23), Glioma Diagnosis and Treatment(20)

Publications256 total

Data from Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma
2023Open Access
Supplementary Figures 1 - 5, Tables 1 - 3 from Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma
2023Open Access
Supplementary Movie 1 from Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma
2023Open Access
Supplementary Figures 1 - 5, Tables 1 - 3 from Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma
2023Open Access
Supplementary Movie 2 from Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma
2023Open Access
Data from Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma
2023Open Access
Supplementary Movie 1 from Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma
2023Open Access
Supplementary Movie 2 from Discriminant Analysis of <sup>18</sup>F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma
2023Open Access
Modular radiochemistry synthesis system
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2023· 1 citedOpen Access
Synthesis of N-formyl-3,4-di-t-butoxycarbonyloxy-6-(trimethylstannyl)-L-phenylalanine ethyl ester and its regioselective radiofluorodestannylation to 6- .sup.18 F!fluoro-1-dopa
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2023Open Access
Nucleophilic fluorination of aromatic compounds
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2023Open Access
Synthesis of N-formyl-3,4-di-t-butoxycarbonyloxy-6-(trimethylstannyl)-L-phenylalanine ethyl ester and its regioselective radiofluorodestannylation to 6-[.sup.18 F]fluoro-L-dopa
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2023Open Access
Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials
Journal of Alzheimer s Disease·2022· 16 citedOpen Access
Does 2-FDG PET Accurately Reflect Quantitative In Vivo Glucose Utilization?
Journal of Nuclear Medicine·2019· 46 citedOpen Access
FDDNP-PET Tau Brain Protein Binding Patterns in Military Personnel with Suspected Chronic Traumatic Encephalopathy1
Journal of Alzheimer s Disease·2018· 46 citedOpen Access
The Value of In Vitro Binding as Predictor of In Vivo Results: A Case for [18F]FDDNP PET
Molecular Imaging and Biology·2018· 7 cited
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial
American Journal of Geriatric Psychiatry·2017· 317 citedOpen Access
Postmortem Autopsy-Confirmation of Antemortem [F-18]FDDNP-PET Scans in a Football Player With Chronic Traumatic Encephalopathy
Neurosurgery·2017· 80 cited
Efficient synthesis of 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) and 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]FHPG)
Journal of Fluorine Chemistry·2017· 4 cited
[P4–025]: MEMORY AND BRAIN AMYLOID AND TAU EFFECTS OF CURCUMIN IN NON‐DEMENTED ADULTS: A DOUBLE‐BLIND, PLACEBO‐CONTROLLED 18‐MONTH TRIAL
Alzheimer s & Dementia·2017Open Access
page 1 of 13Next →

Frequent Co-authors

Jorge R. Barrio(30), Michael E. Phelps(21), Sanjiv S. Gambhir(12), Harvey R. Herschman(12), Mohammad Namavari(11), Vladimir Kepe(10), Johannes Czernin(8), Sung‐Cheng Huang(7), Jorge R. Barrio(7), Gary W. Small(6), Linda M. Ercoli(6), Simon R. Cherry(6), Daniel Silverman(6), T. TOYOKUNI(6), Michael E. Phelps(6), Prabha Siddarth(5), Lily Wu(5), Magnus Dahlbom(5), Meera Iyer(4), Eileen Bauer(4)